Last reviewed · How we verify
Facial Cleanser and Moisturizer SPF 30
This topical product provides physical and chemical sun protection while cleansing and moisturizing the facial skin.
This topical product provides physical and chemical sun protection while cleansing and moisturizing the facial skin. Used for Daily facial cleansing and sun protection (SPF 30).
At a glance
| Generic name | Facial Cleanser and Moisturizer SPF 30 |
|---|---|
| Also known as | Cetaphil® DermaControl™ skin care products |
| Sponsor | Galderma R&D |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
The product combines facial cleansing agents to remove dirt and oil, moisturizing ingredients to hydrate the skin, and SPF 30 sunscreen (likely containing UV filters such as organic and/or inorganic agents) to protect against UVA and UVB radiation. The sunscreen component works by either absorbing UV radiation (chemical filters) or reflecting it (physical filters), while the cleansing and moisturizing components maintain skin barrier function and hydration.
Approved indications
- Daily facial cleansing and sun protection (SPF 30)
Common side effects
- Skin irritation
- Contact dermatitis
- Photosensitivity reaction
Key clinical trials
- A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation (NA)
- Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzpatrick Skin Types V and VI (NA)
- A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation (NA)
- Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation (NA)
- Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. (PHASE4)
- A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Facial Cleanser and Moisturizer SPF 30 CI brief — competitive landscape report
- Facial Cleanser and Moisturizer SPF 30 updates RSS · CI watch RSS
- Galderma R&D portfolio CI